Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice

bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice Huang, Zhihong, Ke Chen, Paul L. Huang, Seth P. Finklestein, Michael A. Moskowitz. ameliorates ischemic injury by blood flow-independent mechanisms mutant . Am. J. Physiol. 272 (Heart Circ. Physiol. 41): Hl401-H1405, 1996.-Genetically engineered deficient in the expression of type III nitric oxide synthase (NOS) [endothelial NOS (eNOS>] were used to decipher the importance of nitric oxide (NO)-dependent augmentation of regional cerebral blood flow (rCBF) to infarct volume reduction following basic fibroblast growth factor () in f us1‘o n d uring acute middle cerebral artery (MCA) * occlusion. We have shown previously that intravenously administered reduces infarct volume following MCA occlusion in rats that dilates cerebral pial arterioles by NO-dependent mechanisms. Halothane-anesthetized eNOS wild-type were subjected to permanent MCA occlusion by intraluminal filament for 24 h. (100 pg. kg-l+ h-l) was infused intravenously for 2 h, beginning 15 min after the onset of occlusion. Infarct volume was reduced from 119 ? 8 to 93 t 4 mm3 (22% reduction, P < 0.05) or from 102 t 9 to 77 2 6 mm3 (24% reduction, P < 0.05) or wild-type , respectively (means t SE; n = 10 per group), neurological deficits were also significantly reduced. Although infusion caused a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AJP - Heart and Circulatory Physiology The American Physiological Society

bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice

Loading next page...
 
/lp/the-american-physiological-society/bfgf-ameliorates-focal-ischemic-injury-by-blood-flow-independent-URf1oZgWa5

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
The American Physiological Society
Copyright
Copyright © 1997 the American Physiological Society
ISSN
0363-6135
eISSN
1522-1539
Publisher site
See Article on Publisher Site

Abstract

Huang, Zhihong, Ke Chen, Paul L. Huang, Seth P. Finklestein, Michael A. Moskowitz. ameliorates ischemic injury by blood flow-independent mechanisms mutant . Am. J. Physiol. 272 (Heart Circ. Physiol. 41): Hl401-H1405, 1996.-Genetically engineered deficient in the expression of type III nitric oxide synthase (NOS) [endothelial NOS (eNOS>] were used to decipher the importance of nitric oxide (NO)-dependent augmentation of regional cerebral blood flow (rCBF) to infarct volume reduction following basic fibroblast growth factor () in f us1‘o n d uring acute middle cerebral artery (MCA) * occlusion. We have shown previously that intravenously administered reduces infarct volume following MCA occlusion in rats that dilates cerebral pial arterioles by NO-dependent mechanisms. Halothane-anesthetized eNOS wild-type were subjected to permanent MCA occlusion by intraluminal filament for 24 h. (100 pg. kg-l+ h-l) was infused intravenously for 2 h, beginning 15 min after the onset of occlusion. Infarct volume was reduced from 119 ? 8 to 93 t 4 mm3 (22% reduction, P < 0.05) or from 102 t 9 to 77 2 6 mm3 (24% reduction, P < 0.05) or wild-type , respectively (means t SE; n = 10 per group), neurological deficits were also significantly reduced. Although infusion caused a

Journal

AJP - Heart and Circulatory PhysiologyThe American Physiological Society

Published: Mar 1, 1997

There are no references for this article.